Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.

Carryn S, Feyssaguet M, Povey M, Di Paolo E.

Vaccine. 2019 Aug 23;37(36):5323-5331. doi: 10.1016/j.vaccine.2019.07.049. Epub 2019 Jul 22.

2.

Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates.

Ravault S, Friel D, Di Paolo E, Caplanusi A, Gillard P, Povey M, Carryn S.

J Infect Dis. 2019 Sep 26;220(9):1462-1468. doi: 10.1093/infdis/jiz345.

3.

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.

Klein NP, Abu-Elyazeed R, Povey M, Macias Parra M, Diez-Domingo J, Ahonen A, Korhonen T, Tinoco JC, Weiner L, Marshall GS, Silas PE, Sarpong KO, Ramsey KP, Fling JA, Speicher D, Campos M, Munjal I, Peltier C, Vesikari T, Baccarini C, Caplanusi A, Gillard P, Carryn S, Henry O.

J Pediatric Infect Dis Soc. 2019 Mar 8. pii: piz010. doi: 10.1093/jpids/piz010. [Epub ahead of print]

PMID:
30849175
4.

The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting.

Sauboin C, Holl K, Bonanni P, Gershon AA, Benninghoff B, Carryn S, Burgess MA, Wutzler P.

BMC Infect Dis. 2019 Feb 6;19(1):126. doi: 10.1186/s12879-019-3759-z.

5.

Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.

Laterre PF, Wittebole X, Van de Velde S, Muller AE, Mouton JW, Carryn S, Tulkens PM, Dugernier T.

J Antimicrob Chemother. 2015 Mar;70(3):891-8. doi: 10.1093/jac/dku465. Epub 2014 Nov 27.

PMID:
25433006
6.

Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae.

Balakrishnan I, Awad-El-Kariem FM, Aali A, Kumari P, Mulla R, Tan B, Brudney D, Ladenheim D, Ghazy A, Khan I, Virgincar N, Iyer S, Carryn S, Van de Velde S.

J Antimicrob Chemother. 2011 Nov;66(11):2628-31. doi: 10.1093/jac/dkr317. Epub 2011 Aug 2.

PMID:
21810837
7.

Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms.

Carryn S, Schaefer DA, Imboden M, Homan EJ, Bremel RD, Riggs MW.

J Parasitol. 2012 Feb;98(1):199-204. doi: 10.1645/GE-2822.1. Epub 2011 Jul 25.

PMID:
21787211
8.

Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients.

Carryn S, Couwenbergh N, Tulkens PM.

J Antimicrob Chemother. 2010 Sep;65(9):2045-6. doi: 10.1093/jac/dkq229. Epub 2010 Jun 24. No abstract available.

PMID:
20576638
9.

Stability of meropenem and doripenem solutions for administration by continuous infusion.

Berthoin K, Le Duff CS, Marchand-Brynaert J, Carryn S, Tulkens PM.

J Antimicrob Chemother. 2010 May;65(5):1073-5. doi: 10.1093/jac/dkq044. Epub 2010 Feb 21. No abstract available.

PMID:
20176578
10.

Penicillin-binding proteins (PBP) and Lmo0441 (a PBP-like protein) play a role in Beta-lactam sensitivity of Listeria monocytogenes.

Van de Velde S, Carryn S, Van Bambeke F, Hill C, Tulkens PM, Sleator RD.

Gut Pathog. 2009 Dec 15;1:23. doi: 10.1186/1757-4749-1-23.

11.

Isolation and 2-D-DIGE proteomic analysis of intracellular and extracellular forms of Listeria monocytogenes.

Van de Velde S, Delaive E, Dieu M, Carryn S, Van Bambeke F, Devreese B, Raes M, Tulkens PM.

Proteomics. 2009 Dec;9(24):5484-96. doi: 10.1002/pmic.200900503.

PMID:
19834917
12.

Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections.

Berthoin K, Ampe E, Tulkens PM, Carryn S.

Int J Antimicrob Agents. 2009 Dec;34(6):555-60. doi: 10.1016/j.ijantimicag.2009.08.005. Epub 2009 Sep 26.

PMID:
19782538
13.

Temocillin in cystic fibrosis: a retrospective pilot study.

Kent L, Bradley JM, France M, Döring G, Carryn S, Bradbury I, Rendall J, Jones A, Elborn JS.

J Cyst Fibros. 2008 Nov;7(6):551-4. doi: 10.1016/j.jcf.2008.06.005. Epub 2008 Aug 15.

14.
15.

Design and evaluation of analogues of the bacterial cell-wall peptidoglycan motif L-Lys-D-Ala-D-Ala for use in a vancomycin biosensor.

Hernout O, Berthoin K, Delattre I, Tulkens PM, Carryn S, Marchand-Brynaert J.

Bioorg Med Chem Lett. 2007 Nov 1;17(21):5758-62. Epub 2007 Aug 28.

PMID:
17855088
16.

Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.

Van Bambeke F, Carryn S, Seral C, Chanteux H, Tyteca D, Mingeot-Leclercq MP, Tulkens PM.

Antimicrob Agents Chemother. 2004 Aug;48(8):2853-60.

17.

Inhibition of TNF-alpha production in THP-1 macrophages by glatiramer acetate does not alter their susceptibility to infection by Listeria monocytogenes and does not impair the efficacy of ampicillin or moxifloxacin against intracellular bacteria.

Ben Abdelaziz H, Lemaire S, Carryn S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.

J Antimicrob Chemother. 2004 Jul;54(1):288-9. Epub 2004 Jun 9. No abstract available.

PMID:
15190038
18.

Impairment of growth of Listeria monocytogenes in THP-1 macrophages by granulocyte macrophage colony-stimulating factor: release of tumor necrosis factor-alpha and nitric oxide.

Carryn S, Van de Velde S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.

J Infect Dis. 2004 Jun 1;189(11):2101-9. Epub 2004 May 12.

PMID:
15143479
19.

Intracellular pharmacodynamics of antibiotics.

Carryn S, Chanteux H, Seral C, Mingeot-Leclercq MP, Van Bambeke F, Tulkens PM.

Infect Dis Clin North Am. 2003 Sep;17(3):615-34. Review.

PMID:
14711080
20.
21.

Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model.

Carryn S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.

J Antimicrob Chemother. 2003 Apr;51(4):1051-2. Epub 2003 Mar 13. No abstract available.

PMID:
12654747

Supplemental Content

Loading ...
Support Center